Translation of "common mammalian cell line " (English → French) :

65. Expects the Commission to reflect on current challenges in the environment and health fields, where the state of the environment adversely affects human health, and to make progress on the planned strategies, in particular scientifically-based horizontal criteria for endocrine disruptors, referred to in the 7th Environment Action Programme; stresses the need for a step forward towards a common European Health Technology Assessment (HTA) at EU level that does not create an extra layer of administrative burden and the need to tackle antimicrobial resistance; expects to receive the secondary legislation provided for under the Tobacco ...[+++]Products Directive; stresses the need for an urgent review of the Tissues and Cells Directive, to bring it in line with the principle of unpaid donation, and the Advanced Therapies Regulation, which needs to be made more applicable to SMEs;

65. Expects the Commission to reflect on current challenges in the environment and health fields, where the state of the environment adversely affects human health, and to make progress on the planned strategies, in particular scientifically-based horizontal criteria for endocrine disruptors, referred to in the 7th Environment Action Programme; stresses the need for a step forward towards a common European Health Technology Assessment (HTA) at EU level that does not create an extra layer of administrative burden and the need to tackle antimicrobial resistance; expects to receive the secondary legislation provided for under the Tobacco ...[+++]Products Directive; stresses the need for an urgent review of the Tissues and Cells Directive, to bring it in line with the principle of unpaid donation, and the Advanced Therapies Regulation, which needs to be made more applicable to SMEs;

42. Stresses the need for an urgent review of the Tissues and Cells Directive to bring it in line with the Charter of Fundamental Rights, in particular as regards the principle of unpaid donation; takes the view that the same applies to the Advanced Therapies Regulation, which also needs to be made more applicable to SMEs; stresses to the Commission the need to come forward with a proposal for a more common approach to health technology assessment (HTA) for pharmaceutica ...[+++]ls that does not create an extra layer of administrative burden, but instead unburdens companies and Member States’ authorities by requiring them to carry out such assessment only once, at the European level, rather than in the 28 Member States; expects the timely adoption of secondary legislation provided for under the Tobacco Products Directive; stresses that the Commission should make the fight against antimicrobial resistance a priority, and asks for concrete legislative proposals to tackle these serious problems, in addition to the existing proposals in the veterinary field; calls also for greater attention to be focused on human medicine, for example in the form of an instrument governing antibiotics for human use similar to that already proposed for antibiotics in the veterinary field;

Protocols should be in line with OECD Guideline 471 (Salmonella typhimurium Reverse Mutation Test), 472 (Escherichia coli Reverse Mutation Test), 473 (in vitro Mammalian Chromosomal Aberration Test), 474 (Mammalian Erythrocyte Micronucleus Test), 475 (Mammalian Bone Marrow Chromosomal Aberration Test), 476 (in vitro Mammalian Cell Gene Mutation Test) or 482 (Unscheduled DNA Synthesis in Mammalian Cells in vitro), as well as other r ...[+++]elevant OECD Guidelines for in vitro and in vivo assays.

This is why I drew up a new compromise proposal, in order to find some common ground between scientific demands and ethical principles: indeed, my proposal – put forward by the PPE-DE Group, moreover – on the one hand, bans the funding of research projects which provide for the use of human supernumerary embryos, and, on the other, allows research scientists to use in experiments stem cells and stem cell lines from human embryos which are already available in laboratories and which were taken from supernumerary embryos before 27 June ...[+++]2002.

This is why I drew up a new compromise proposal, in order to find some common ground between scientific demands and ethical principles: indeed, my proposal – put forward by the PPE-DE Group, moreover – on the one hand, bans the funding of research projects which provide for the use of human supernumerary embryos, and, on the other, allows research scientists to use in experiments stem cells and stem cell lines from human embryos which are already available in laboratories and which were taken from supernumerary embryos before 27 June ...[+++]2002.